Listeria monocytogenes bacteremia developed during treatment of COVID-19

Jin Yamamoto; Keitaro Nakamoto; Teppei Shimasaki; Daisuke Kurai; Takeshi Saraya; Haruyuki Ishii

doi:10.1002/ccr3.8115

Listeria monocytogenes bacteremia developed during treatment of COVID-19

Clin Case Rep. 2023 Oct 29;11(11):e8115. doi: 10.1002/ccr3.8115. eCollection 2023 Nov.

Authors

Jin Yamamoto¹, Keitaro Nakamoto², Teppei Shimasaki³, Daisuke Kurai³, Takeshi Saraya², Haruyuki Ishii²

Affiliations

¹ Department of Nephrology and Rheumatology Kyorin University School of Medicine Mitaka Tokyo Japan.
² Department of Respiratory Medicine Kyorin University School of Medicine Mitaka Tokyo Japan.
³ Department of General Medicine Kyorin University School of Medicine Mitaka Tokyo Japan.

Abstract

Listeria monocytogenes is an important pathogen in older patients and immunosuppressed patients, often causing bacteremia. Complications resulting from infections other than COVID-19 must also be considered during COVID-19 treatment.

Keywords: COVID‐19; Listeria monocytogenes; bacteremia.

Publication types

Case Reports